Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
gptkb:tenofovir_alafenamide
|
| gptkbp:ATCCode |
J05AF13
|
| gptkbp:CASNumber |
379270-37-8
|
| gptkbp:category |
antiviral drug
nucleotide reverse transcriptase inhibitor |
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| gptkbp:hasMolecularFormula |
C21H29N6O5P
|
| https://www.w3.org/2000/01/rdf-schema#label |
alafenamide
|
| gptkbp:prodrugOf |
tenofovir
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
HIV infection
prodrug chronic hepatitis B |
| gptkbp:bfsParent |
gptkb:tenofovir_disoproxil_fumarate
|
| gptkbp:bfsLayer |
6
|